首页 > 最新文献

Tropical Diseases, Travel Medicine and Vaccines最新文献

英文 中文
Putting the mouth back in the body - the neglected area of dental and oral travel health.
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-03-15 DOI: 10.1186/s40794-024-00242-z
Irmgard L Bauer

The lack of dental travel health care has been deplored for some time. Travel medicine's remit is to prepare people for travel. People travel with their mouth firmly in their body, yet the mouth's wellbeing does not rate a mention. This article represents the first exploration of a range of topics relevant to an until now neglected, yet potentially highly important, area of health care. A range of dental mishaps can occur while away from home, from simple toothache to accidents, serious emergencies, or restoration failures. Other problems originate in unwise behaviour, including holiday-inspired body modifications.Unless there is pain, teeth are typically not thought about much. However, examining the practical side of dental hygiene during travels, several overlooked and perhaps surprising topics emerge that - through the travel lens - take on a different and important role: the oral microbiome, toothbrush hygiene, the toilet plume, and traveller diarrhoea. Based on this discussion, recommendations are made for clinical practice, education, and further research.The historical chasm between dentistry and medicine, despite long-standing calls for change, does not seem to go away and impairs holistic high quality travel health care. Travel medicine can bypass this unproductive division. It has the unique opportunity to be the first medical specialty cooperating closely with dentists to bridge this gap by providing quality travel health care to travellers with all their body parts attached.

{"title":"Putting the mouth back in the body - the neglected area of dental and oral travel health.","authors":"Irmgard L Bauer","doi":"10.1186/s40794-024-00242-z","DOIUrl":"10.1186/s40794-024-00242-z","url":null,"abstract":"<p><p>The lack of dental travel health care has been deplored for some time. Travel medicine's remit is to prepare people for travel. People travel with their mouth firmly in their body, yet the mouth's wellbeing does not rate a mention. This article represents the first exploration of a range of topics relevant to an until now neglected, yet potentially highly important, area of health care. A range of dental mishaps can occur while away from home, from simple toothache to accidents, serious emergencies, or restoration failures. Other problems originate in unwise behaviour, including holiday-inspired body modifications.Unless there is pain, teeth are typically not thought about much. However, examining the practical side of dental hygiene during travels, several overlooked and perhaps surprising topics emerge that - through the travel lens - take on a different and important role: the oral microbiome, toothbrush hygiene, the toilet plume, and traveller diarrhoea. Based on this discussion, recommendations are made for clinical practice, education, and further research.The historical chasm between dentistry and medicine, despite long-standing calls for change, does not seem to go away and impairs holistic high quality travel health care. Travel medicine can bypass this unproductive division. It has the unique opportunity to be the first medical specialty cooperating closely with dentists to bridge this gap by providing quality travel health care to travellers with all their body parts attached.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"7"},"PeriodicalIF":2.4,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of COVID-19 on a medium-sized travel medicine clinic in eastern Pennsylvania, USA.
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-03-01 DOI: 10.1186/s40794-024-00239-8
Pravallika Palwai, Marcelo Gareca, Sowmya R Rao, Mark C Knouse

Background: The COVID-19 pandemic (COVID) disrupted international travel. We sought to determine the impact of the COVID-19 pandemic on patient volume, traveler demographics, and income of our medium-sized travel clinic in Pennsylvania, USA.

Methods: We extracted de-identified pre-travel data on 3,510 pre-travel consultations for adults during: Pre-COVID-19 (January 2018-December 2019), Early COVID-19 (April 2020-March 2022) and Late COVID-19 (April 2022-March 2023). We compared traveler demographics, destinations, purpose of travel, medical conditions, and number of vaccinations administered over time, and our clinic's revenue obtained from our financial database (TruSource) for the Pre, Early and Late COVID-19 periods.

Results: We observed 84% and 85% relative decreases in traveler volume and revenue respectively from the Pre-COVID-19 to the Early COVID-19 period. The decrease (16-11%) in volume was highest for travelers over 65 years of age. Of those that sought care during Early COVID-19, a fewer proportion of travelers had multiple co-morbid conditions and were taking chronic medications. Trip length increased and there was a significant increase in travel to Africa. Travel to visit friends or family and for service work also increased during Early-COVID-19 (32.9%) versus Pre-COVID-19 (19.8%). Clinic volume and revenue began to increase in Late COVID-19 but did not return to Pre-COVID levels.

Conclusions: The COVID pandemic resulted in a large reduction in patient volume and revenue in our academic-based Pennsylvania travel clinic. We saw substantial changes in our traveler demographics, destinations, as well as reasons and durations of travel. Smaller travel clinics will need to have plans in place in order to survive the next pandemic and better serve their pre-travel populations.

{"title":"Impact of COVID-19 on a medium-sized travel medicine clinic in eastern Pennsylvania, USA.","authors":"Pravallika Palwai, Marcelo Gareca, Sowmya R Rao, Mark C Knouse","doi":"10.1186/s40794-024-00239-8","DOIUrl":"10.1186/s40794-024-00239-8","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic (COVID) disrupted international travel. We sought to determine the impact of the COVID-19 pandemic on patient volume, traveler demographics, and income of our medium-sized travel clinic in Pennsylvania, USA.</p><p><strong>Methods: </strong>We extracted de-identified pre-travel data on 3,510 pre-travel consultations for adults during: Pre-COVID-19 (January 2018-December 2019), Early COVID-19 (April 2020-March 2022) and Late COVID-19 (April 2022-March 2023). We compared traveler demographics, destinations, purpose of travel, medical conditions, and number of vaccinations administered over time, and our clinic's revenue obtained from our financial database (TruSource) for the Pre, Early and Late COVID-19 periods.</p><p><strong>Results: </strong>We observed 84% and 85% relative decreases in traveler volume and revenue respectively from the Pre-COVID-19 to the Early COVID-19 period. The decrease (16-11%) in volume was highest for travelers over 65 years of age. Of those that sought care during Early COVID-19, a fewer proportion of travelers had multiple co-morbid conditions and were taking chronic medications. Trip length increased and there was a significant increase in travel to Africa. Travel to visit friends or family and for service work also increased during Early-COVID-19 (32.9%) versus Pre-COVID-19 (19.8%). Clinic volume and revenue began to increase in Late COVID-19 but did not return to Pre-COVID levels.</p><p><strong>Conclusions: </strong>The COVID pandemic resulted in a large reduction in patient volume and revenue in our academic-based Pennsylvania travel clinic. We saw substantial changes in our traveler demographics, destinations, as well as reasons and durations of travel. Smaller travel clinics will need to have plans in place in order to survive the next pandemic and better serve their pre-travel populations.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"5"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ear, nose and throat disorders and international travel.
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-15 DOI: 10.1186/s40794-024-00238-9
Nathaniel McHugh, Robert E Lyons, Ivan Keogh, Gerard T Flaherty

Background: Disorders of the ear, nose and throat may be the most commonly occurring pre-existing health condition in international travellers. Despite their high incidence, there is limited guidance for travellers and their clinicians on their prevention and management. This narrative review addresses this deficit by compiling and discussing available evidence on this neglected subject.

Methods: A comprehensive review of the literature was undertaken using Medine and Scopus databases and multiple combinations of relevant MeSH search terms. Further references were obtained from focused searches on specific issues and manual review of the reference lists of articles obtained from the primary search.

Results: Nasal congestion or discharge are among the most common complaints amongst travellers and various causes are reviewed. Changes in elevation result in a pressure differential between the atmospheric pressure and the middle ear and paranasal sinuses. The effects of air travel, recreational high-altitude exposure and diving are considered. Various causes of epistaxis in travellers such as cold air exposure and recreational cocaine use are discussed. The aetiology of a discharging ear in travellers includes otitis externa. The most frequently described travel-specific aetiology of dizziness is motion sickness while mal de debarquement is a specific subtype which affects travellers and is most commonly associated with sea travel. Surgical tourism for treatment of ear, nose and throat pathology is well established and various precautions are presented for post-operative travel. Obstructive sleep apnoea is discussed from the perspective of international travel. The challenges facing travellers with hearing impairment are explored.

Conclusions: This review critically discusses the prevention, diagnosis, and management of acute and chronic ENT conditions in the travelling population. Several areas of inquiry are highlighted that require further investigation. Close communication between ENT specialists and travel medicine practitioners is recommended in the preparation of selected patients for international travel.

{"title":"Ear, nose and throat disorders and international travel.","authors":"Nathaniel McHugh, Robert E Lyons, Ivan Keogh, Gerard T Flaherty","doi":"10.1186/s40794-024-00238-9","DOIUrl":"10.1186/s40794-024-00238-9","url":null,"abstract":"<p><strong>Background: </strong>Disorders of the ear, nose and throat may be the most commonly occurring pre-existing health condition in international travellers. Despite their high incidence, there is limited guidance for travellers and their clinicians on their prevention and management. This narrative review addresses this deficit by compiling and discussing available evidence on this neglected subject.</p><p><strong>Methods: </strong>A comprehensive review of the literature was undertaken using Medine and Scopus databases and multiple combinations of relevant MeSH search terms. Further references were obtained from focused searches on specific issues and manual review of the reference lists of articles obtained from the primary search.</p><p><strong>Results: </strong>Nasal congestion or discharge are among the most common complaints amongst travellers and various causes are reviewed. Changes in elevation result in a pressure differential between the atmospheric pressure and the middle ear and paranasal sinuses. The effects of air travel, recreational high-altitude exposure and diving are considered. Various causes of epistaxis in travellers such as cold air exposure and recreational cocaine use are discussed. The aetiology of a discharging ear in travellers includes otitis externa. The most frequently described travel-specific aetiology of dizziness is motion sickness while mal de debarquement is a specific subtype which affects travellers and is most commonly associated with sea travel. Surgical tourism for treatment of ear, nose and throat pathology is well established and various precautions are presented for post-operative travel. Obstructive sleep apnoea is discussed from the perspective of international travel. The challenges facing travellers with hearing impairment are explored.</p><p><strong>Conclusions: </strong>This review critically discusses the prevention, diagnosis, and management of acute and chronic ENT conditions in the travelling population. Several areas of inquiry are highlighted that require further investigation. Close communication between ENT specialists and travel medicine practitioners is recommended in the preparation of selected patients for international travel.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"3"},"PeriodicalIF":2.4,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11829402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143426404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring primary care physicians' role in travel medicine: a scoping review of knowledge, practices, and training.
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1186/s40794-024-00233-0
Ayman Al-Dahshan, Salma Ahmed, Anwar Joudeh, Vahe Kehyayan

Background: With the surge in international travel, primary care physicians (PCPs) play a critical role in managing travel medicine (TM) challenges. This scoping review aims to comprehensively synthesize literature on PCPs' involvement in TM, covering their knowledge, practices, and training.

Methods: Systematic searches across various electronic databases identified empirical studies in English language peer-reviewed journals up to July 2023. Data synthesis involved charting evidence on PCPs' TM knowledge, practices, and training.

Results: Sixteen articles met inclusion criteria, offering insights into PCPs' engagement with TM in primary care. The findings reveal a general deficiency in PCPs' TM knowledge, with factors like prior TM experience, formal training, high traveler exposure, and multilingual abilities predicting higher knowledge scores. TM consultation duration and documentation were frequently reported as insufficient. Barriers to effective TM provision included physician-related factors such as lack of formal training, traveler-related factors like delayed presentation and low-risk perception, and practice-related factors such as low traveler exposure and resource constraints.

Conclusion: This review underscores the crucial role of PCPs in TM and the need for targeted interventions to enhance their expertise and practices. Overcoming barriers through tailored training and support is essential for optimizing TM delivery in primary care.

{"title":"Exploring primary care physicians' role in travel medicine: a scoping review of knowledge, practices, and training.","authors":"Ayman Al-Dahshan, Salma Ahmed, Anwar Joudeh, Vahe Kehyayan","doi":"10.1186/s40794-024-00233-0","DOIUrl":"10.1186/s40794-024-00233-0","url":null,"abstract":"<p><strong>Background: </strong>With the surge in international travel, primary care physicians (PCPs) play a critical role in managing travel medicine (TM) challenges. This scoping review aims to comprehensively synthesize literature on PCPs' involvement in TM, covering their knowledge, practices, and training.</p><p><strong>Methods: </strong>Systematic searches across various electronic databases identified empirical studies in English language peer-reviewed journals up to July 2023. Data synthesis involved charting evidence on PCPs' TM knowledge, practices, and training.</p><p><strong>Results: </strong>Sixteen articles met inclusion criteria, offering insights into PCPs' engagement with TM in primary care. The findings reveal a general deficiency in PCPs' TM knowledge, with factors like prior TM experience, formal training, high traveler exposure, and multilingual abilities predicting higher knowledge scores. TM consultation duration and documentation were frequently reported as insufficient. Barriers to effective TM provision included physician-related factors such as lack of formal training, traveler-related factors like delayed presentation and low-risk perception, and practice-related factors such as low traveler exposure and resource constraints.</p><p><strong>Conclusion: </strong>This review underscores the crucial role of PCPs in TM and the need for targeted interventions to enhance their expertise and practices. Overcoming barriers through tailored training and support is essential for optimizing TM delivery in primary care.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"4"},"PeriodicalIF":2.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11786444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143075579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monkeypox: a re-emergent virus with global health implications - a comprehensive review. 猴痘:一种具有全球卫生影响的重新出现的病毒——一项全面审查。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-01-15 DOI: 10.1186/s40794-024-00237-w
Nourhan G Naga, Enas A Nawar, A'laa A Mobarak, Aya G Faramawy, Hend M H Al-Kordy

Monkeypox virus (MPXV) is an enclosed, double-stranded DNA virus from the Orthopoxvirus genus, which also contains variola, vaccinia, and cowpox. MPXV, which was once confined to West and Central Africa, has recently had a rebound, spreading beyond its original range since 2017. The virus is distinguished by its unique morphology, which includes an oval or brick-shaped structure and a complex lipid and protein makeup. The current multi-country outbreak designated a public health emergency in 2022, has highlighted MPXV's shifting epidemiology and ability to spread rapidly over the globe. 'No one is safe until everyone is safe' is a slogan we often heard during the COVID-19 pandemic, which is now also required for the growing global and regional mpox outbreaks. The epidemic is divided into two clades: Clade I and Clade II, which have distinct pathogenic characteristics. Diagnostic approaches have developed with advances in molecular techniques, yet problems persist in resource-constrained situations. This overview summarizes the virus's history, epidemiology, morphology, and clinical characteristics, offering insights into its recent comeback and current global response efforts.

猴痘病毒(MPXV)是一种封闭的双链DNA病毒,来自正痘病毒属,它还含有天花、牛痘和牛痘。MPXV曾经局限于西非和中非,最近出现反弹,自2017年以来蔓延到其原始范围之外。该病毒的特点是其独特的形态,包括椭圆形或砖状结构以及复杂的脂质和蛋白质组成。目前的多国疫情在2022年被指定为突发公共卫生事件,突显了MPXV的流行病学变化以及在全球迅速传播的能力。“人人安全,无人安全”是我们在2019冠状病毒病大流行期间经常听到的口号,现在全球和区域麻疹疫情日益严重,也需要这一口号。该流行病分为两个分支:分支I和分支II,它们具有不同的致病特征。随着分子技术的进步,诊断方法得到了发展,但在资源有限的情况下,问题仍然存在。本综述总结了该病毒的历史、流行病学、形态和临床特征,为其最近的卷土重来和当前的全球应对工作提供了见解。
{"title":"Monkeypox: a re-emergent virus with global health implications - a comprehensive review.","authors":"Nourhan G Naga, Enas A Nawar, A'laa A Mobarak, Aya G Faramawy, Hend M H Al-Kordy","doi":"10.1186/s40794-024-00237-w","DOIUrl":"10.1186/s40794-024-00237-w","url":null,"abstract":"<p><p>Monkeypox virus (MPXV) is an enclosed, double-stranded DNA virus from the Orthopoxvirus genus, which also contains variola, vaccinia, and cowpox. MPXV, which was once confined to West and Central Africa, has recently had a rebound, spreading beyond its original range since 2017. The virus is distinguished by its unique morphology, which includes an oval or brick-shaped structure and a complex lipid and protein makeup. The current multi-country outbreak designated a public health emergency in 2022, has highlighted MPXV's shifting epidemiology and ability to spread rapidly over the globe. 'No one is safe until everyone is safe' is a slogan we often heard during the COVID-19 pandemic, which is now also required for the growing global and regional mpox outbreaks. The epidemic is divided into two clades: Clade I and Clade II, which have distinct pathogenic characteristics. Diagnostic approaches have developed with advances in molecular techniques, yet problems persist in resource-constrained situations. This overview summarizes the virus's history, epidemiology, morphology, and clinical characteristics, offering insights into its recent comeback and current global response efforts.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"2"},"PeriodicalIF":2.4,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems. 应对新出现的Oropouche病毒威胁:对卫生保健系统的影响和公共卫生应对。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2025-01-02 DOI: 10.1186/s40794-024-00236-x
Olalekan John Okesanya, Blessing Olawumi Amisu, Olaniyi Abideen Adigun, Mohamed Mustaf Ahmed, Abdulmajeed Opeyemi Agboola, Tolga Kab, Gilbert Eshun, Bonaventure Michael Ukoaka, Tolutope Adebimpe Oso, Jerico Bautista Ogaya, Don Eliseo Lucero-Prisno

Oropouche fever is an increasingly significant health concern in tropical and subtropical areas of South and Central America, and is primarily spread by midge vectors. The Oropouche virus (OROV) was first identified in 1955 and has been responsible for numerous outbreaks, particularly in urban environments. Despite its prevalence, the disease is often under-reported, making it difficult to fully understand its impact. OROV typically causes febrile illness characterized by symptoms such as headaches, muscle pain, and, occasionally, neurological issues such as meningitis. The ability of the virus to thrive in both forested and urban areas has raised concerns regarding its potential spread to new regions, particularly in the context of climate change. This paper delves into the epidemiology, clinical features, and transmission patterns of OROV, shedding light on the difficulties in diagnosing and managing the disease. The absence of specific treatments and vaccines highlights the urgent need for continued research and development of targeted public health strategies. Advancements in molecular diagnostics and vector control strategies can mitigate Oropouche fever's impact. However, a comprehensive public health approach involving increased surveillance, public education, and cross-border collaboration is needed, especially as the global climate crisis may expand vector habitats, posing risks to previously unaffected regions.

在南美洲和中美洲的热带和亚热带地区,欧罗波切热是一个日益严重的健康问题,主要由蚊媒传播。Oropouche病毒(OROV)于1955年首次发现,并造成了多次疫情,特别是在城市环境中。尽管发病率很高,但该病的报道往往不足,因此很难充分了解其影响。OROV通常会引起发热性疾病,其特征是头痛、肌肉疼痛等症状,偶尔还会出现神经问题,如脑膜炎。该病毒在森林和城市地区茁壮成长的能力引起了人们对其可能传播到新地区的担忧,特别是在气候变化的背景下。本文深入探讨了OROV的流行病学、临床特征和传播模式,揭示了该病诊断和治疗的难点。由于缺乏特定的治疗方法和疫苗,因此迫切需要继续研究和制定有针对性的公共卫生战略。分子诊断和病媒控制策略的进步可以减轻欧罗波切热的影响。但是,需要采取包括加强监测、公共教育和跨界合作在内的综合公共卫生办法,特别是因为全球气候危机可能扩大病媒栖息地,对以前未受影响的地区构成风险。
{"title":"Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems.","authors":"Olalekan John Okesanya, Blessing Olawumi Amisu, Olaniyi Abideen Adigun, Mohamed Mustaf Ahmed, Abdulmajeed Opeyemi Agboola, Tolga Kab, Gilbert Eshun, Bonaventure Michael Ukoaka, Tolutope Adebimpe Oso, Jerico Bautista Ogaya, Don Eliseo Lucero-Prisno","doi":"10.1186/s40794-024-00236-x","DOIUrl":"10.1186/s40794-024-00236-x","url":null,"abstract":"<p><p>Oropouche fever is an increasingly significant health concern in tropical and subtropical areas of South and Central America, and is primarily spread by midge vectors. The Oropouche virus (OROV) was first identified in 1955 and has been responsible for numerous outbreaks, particularly in urban environments. Despite its prevalence, the disease is often under-reported, making it difficult to fully understand its impact. OROV typically causes febrile illness characterized by symptoms such as headaches, muscle pain, and, occasionally, neurological issues such as meningitis. The ability of the virus to thrive in both forested and urban areas has raised concerns regarding its potential spread to new regions, particularly in the context of climate change. This paper delves into the epidemiology, clinical features, and transmission patterns of OROV, shedding light on the difficulties in diagnosing and managing the disease. The absence of specific treatments and vaccines highlights the urgent need for continued research and development of targeted public health strategies. Advancements in molecular diagnostics and vector control strategies can mitigate Oropouche fever's impact. However, a comprehensive public health approach involving increased surveillance, public education, and cross-border collaboration is needed, especially as the global climate crisis may expand vector habitats, posing risks to previously unaffected regions.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"1"},"PeriodicalIF":2.4,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The application of aptamer in tuberculosis diagnosis: a systematic review. 在结核病诊断中应用适配体:系统综述。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-12-15 DOI: 10.1186/s40794-024-00235-y
Elham Isaei, Mohammad Hossein Sobhanipoor, Mehran Rahimlou, Nima Firouzeh

Tuberculosis represents a significant menace to health, leading to millions of cases and fatalities each year. Traditional diagnostic methods, while effective, have limitations, necessitating improved tools. Aptamers possessing remarkable specificity single-stranded DNA or RNA molecules promising in TB diagnosis due to their adaptability and precise biomarker detection capabilities. In this study, we aimed to evaluate the research on aptamer applications in TB diagnosis, evaluating the efficacy, limitations, and future prospects. The present systematic review study followed PRISMA guidelines, including peer-reviewed studies on aptamer efficacy in TB diagnosis. Eligibility criteria covered experimental and human studies on TB diagnosis, prognosis, progression, and treatment response. Of 1165 identified studies, 35 met inclusion criteria. Aptamers were utilized for MTB and mycobacterial antigen detection, showcasing notable sensitivity and specificity. Targeted antigens included ESAT-6, HspX, MPT 64, and IFN-γ. Various aptamer-based assays, such as electrochemical, fluorescent, and immunosensors, demonstrated effectiveness. Multiplex assays, particularly for IFN-γ, showed enhanced diagnostic accuracy. Aptamer-based assays exhibited discrimination between active TB and other conditions, showcasing their diagnostic value. Aptamers, especially in conjunction with nanomaterials, show promise in developing advanced TB biosensors with superior detection capabilities. Cost-effective devices with heightened sensitivity for clinical and screening use are crucial for TB control, emphasizing the need for ongoing research in this field.

结核病是对健康的重大威胁,每年导致数百万病例和死亡。传统的诊断方法虽然有效,但有局限性,需要改进工具。由于其适应性和精确的生物标志物检测能力,具有显著特异性单链DNA或RNA分子的适体有望用于结核病诊断。在本研究中,我们旨在评价适体在结核病诊断中的应用研究,评价其疗效、局限性和未来前景。目前的系统评价研究遵循PRISMA指南,包括关于适体在结核病诊断中的功效的同行评议研究。资格标准包括关于结核病诊断、预后、进展和治疗反应的实验和人体研究。在1165项研究中,35项符合纳入标准。核酸适配体用于MTB和分枝杆菌抗原检测,具有显著的敏感性和特异性。靶向抗原包括ESAT-6、HspX、MPT 64和IFN-γ。各种基于适配体的测定,如电化学、荧光和免疫传感器,证明了其有效性。多重检测,特别是IFN-γ,显示出更高的诊断准确性。基于适配体的检测显示活动性结核病和其他疾病之间的区别,显示了它们的诊断价值。适体,特别是与纳米材料结合,在开发具有卓越检测能力的先进结核病生物传感器方面显示出前景。对临床和筛查使用具有更高灵敏度的具有成本效益的设备对结核病控制至关重要,强调需要在这一领域进行持续研究。
{"title":"The application of aptamer in tuberculosis diagnosis: a systematic review.","authors":"Elham Isaei, Mohammad Hossein Sobhanipoor, Mehran Rahimlou, Nima Firouzeh","doi":"10.1186/s40794-024-00235-y","DOIUrl":"10.1186/s40794-024-00235-y","url":null,"abstract":"<p><p>Tuberculosis represents a significant menace to health, leading to millions of cases and fatalities each year. Traditional diagnostic methods, while effective, have limitations, necessitating improved tools. Aptamers possessing remarkable specificity single-stranded DNA or RNA molecules promising in TB diagnosis due to their adaptability and precise biomarker detection capabilities. In this study, we aimed to evaluate the research on aptamer applications in TB diagnosis, evaluating the efficacy, limitations, and future prospects. The present systematic review study followed PRISMA guidelines, including peer-reviewed studies on aptamer efficacy in TB diagnosis. Eligibility criteria covered experimental and human studies on TB diagnosis, prognosis, progression, and treatment response. Of 1165 identified studies, 35 met inclusion criteria. Aptamers were utilized for MTB and mycobacterial antigen detection, showcasing notable sensitivity and specificity. Targeted antigens included ESAT-6, HspX, MPT 64, and IFN-γ. Various aptamer-based assays, such as electrochemical, fluorescent, and immunosensors, demonstrated effectiveness. Multiplex assays, particularly for IFN-γ, showed enhanced diagnostic accuracy. Aptamer-based assays exhibited discrimination between active TB and other conditions, showcasing their diagnostic value. Aptamers, especially in conjunction with nanomaterials, show promise in developing advanced TB biosensors with superior detection capabilities. Cost-effective devices with heightened sensitivity for clinical and screening use are crucial for TB control, emphasizing the need for ongoing research in this field.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"25"},"PeriodicalIF":2.4,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of climate change in the emergence of human fascioliasis in Upper Egypt. 气候变化在上埃及人类片形吸虫病出现中的意义。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.1186/s40794-024-00234-z
Naglaa Zanaty, Nagat Ibrahim, Haidi Karam-Allah Ramadan, Alzahraa Abdelraouf Ahmad, Amal Saad-Hussein

Background: Climate change in the upcoming years will raise the health burden of zoonotic parasites. As a liver fluke, Fasciola depends on certain climate conditions to complete its life cycle and is significantly influenced by climate changes. We aimed to investigate the relationship between the increasing prevalence of human fascioliasis and climate changes in Upper Egypt.

Methods: Records of Fasciola cases in Assiut Governorate in Upper Egypt were evaluated between September 2018 and March 2023. The annual and monthly climate parameters of the region's temperature and humidity acquired from ERA5 and FLDAS were investigated between 2000 and 2023.

Results: A total of 303 patients were included. The mean age was 33.9 ± 17.4 years; 57.1% were females, and the majority were rural residents. Positive correlations were found between temperature and the recorded cases in 2018, 2020, 2021, and 2022 (r = 0.92, 0.41, 0.61, and 0.60, respectively). In 2018 and 2022, humidity and Fasciola frequency had a significant positive correlation (r = 0.97 and 0.49, respectively). An outbreak of fascioliasis was recorded in September 2018, coinciding with the peak temperature and high humidity levels, exceeding the average climatology range from 2000 to 2017. The recorded cases exhibited a seasonal pattern, with peaks in hot, humid summer and autumn.

Conclusion: The rise of human fascioliasis in Upper Egypt is influenced by local climate characteristics. A climate-based map of Fasciola distribution using forecast risk models is needed to predict future outbreaks and for better control.

背景:未来几年气候变化将增加人畜共患寄生虫的健康负担。片形吸虫是一种肝吸虫,需要一定的气候条件才能完成其生命周期,受气候变化的影响较大。我们的目的是调查上埃及地区人类片形吸虫病日益流行与气候变化之间的关系。方法:对2018年9月至2023年3月上埃及阿西尤特省的片形吸虫病例记录进行评估。利用2000 - 2023年ERA5和FLDAS获取的区域年、月气候参数进行了研究。结果:共纳入303例患者。平均年龄33.9±17.4岁;女性占57.1%,以农村居民居多。2018年、2020年、2021年和2022年气温与病例呈显著正相关(r分别为0.92、0.41、0.61和0.60)。2018年和2022年,湿度与片形吸虫频率呈显著正相关(r分别为0.97和0.49)。2018年9月记录了一次片吸虫病暴发,恰逢气温高峰和高湿水平,超过了2000年至2017年的平均气候学范围。病例呈季节性分布,夏季和秋季为高发季节。结论:上埃及地区人片形吸虫病的流行受当地气候特点的影响。需要使用预测风险模型绘制基于气候的片形虫分布图,以预测未来的疫情和更好地控制。
{"title":"Significance of climate change in the emergence of human fascioliasis in Upper Egypt.","authors":"Naglaa Zanaty, Nagat Ibrahim, Haidi Karam-Allah Ramadan, Alzahraa Abdelraouf Ahmad, Amal Saad-Hussein","doi":"10.1186/s40794-024-00234-z","DOIUrl":"https://doi.org/10.1186/s40794-024-00234-z","url":null,"abstract":"<p><strong>Background: </strong>Climate change in the upcoming years will raise the health burden of zoonotic parasites. As a liver fluke, Fasciola depends on certain climate conditions to complete its life cycle and is significantly influenced by climate changes. We aimed to investigate the relationship between the increasing prevalence of human fascioliasis and climate changes in Upper Egypt.</p><p><strong>Methods: </strong>Records of Fasciola cases in Assiut Governorate in Upper Egypt were evaluated between September 2018 and March 2023. The annual and monthly climate parameters of the region's temperature and humidity acquired from ERA5 and FLDAS were investigated between 2000 and 2023.</p><p><strong>Results: </strong>A total of 303 patients were included. The mean age was 33.9 ± 17.4 years; 57.1% were females, and the majority were rural residents. Positive correlations were found between temperature and the recorded cases in 2018, 2020, 2021, and 2022 (r = 0.92, 0.41, 0.61, and 0.60, respectively). In 2018 and 2022, humidity and Fasciola frequency had a significant positive correlation (r = 0.97 and 0.49, respectively). An outbreak of fascioliasis was recorded in September 2018, coinciding with the peak temperature and high humidity levels, exceeding the average climatology range from 2000 to 2017. The recorded cases exhibited a seasonal pattern, with peaks in hot, humid summer and autumn.</p><p><strong>Conclusion: </strong>The rise of human fascioliasis in Upper Egypt is influenced by local climate characteristics. A climate-based map of Fasciola distribution using forecast risk models is needed to predict future outbreaks and for better control.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"24"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring plant-based dengue therapeutics: from laboratory to clinic. 探索基于植物的登革热疗法:从实验室到临床。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-11-15 DOI: 10.1186/s40794-024-00232-1
Bisma Rehman, Akhlaq Ahmed, Saeed Khan, Nida Saleem, Faiza Naseer, Sagheer Ahmad

Dengue virus (DENV) is a mosquito-borne virus that causes dengue fever, a significant public health concern in many tropical and subtropical regions. Dengue is endemic in more than 100 countries, primarily in tropical and subtropical regions of the world. Each year, up to 400 million people get infected with dengue. Approximately 100 million people get sick from infection, and 40,000 die from severe dengue. Unfortunately, dengue vaccine development is also marred with various complicating factors, as the forefront candidate vaccine performed unsatisfactorily. Moreover, the only licensed vaccine (Dengvaxia) for children 9 through 16 years of age is available in just a few countries. The treatment difficulties are compounded by the absence of an effective antiviral agent. Exploring plant-based therapeutics for dengue from the laboratory to clinical application involves a multi-stage process, encompassing various scientific disciplines. Individual investigators have screened a wide range of plant extracts or compounds for potential antiviral activity against DENV. In vitro studies help identify candidates that exhibit inhibitory effects on viral replication. Some of the most promising medicinal plants showing in vitro activity against DENV include Andrographis paniculate, Acorus calamus, and Cladogynos orientalis. Further laboratory studies, both in vitro and in animal models (in vivo), elucidate the mechanisms of action by which the identified compounds exert antiviral effects. Medicinal plants such as Carica papaya, Cissampelos pareira, and Ipomea batata exhibited potent platelet-enhancing activities while Azadirachta indica and Curcuma longa showed promising effects in both in vitro and in vivo studies. Based on positive preclinical results, researchers design clinical trials. This involves careful planning of trial phases, patient recruitment criteria, ethical considerations, and endpoints. The most important medicinal plants showing efficacy and safety in clinical trials include Carica papaya and Cissampelos pareira. This review suggests that several promising medicinal plants exist that have the potential to be turned into clinical drugs to treat dengue infection. However, in addition to developing synthetic and plant-based therapies against dengue infection, vector management strategies should be made robust, emphasizing the need to focus on reducing disease incidence.

登革热病毒(DENV)是一种由蚊子传播的病毒,可引起登革热,是许多热带和亚热带地区的重大公共卫生问题。登革热在全球 100 多个国家流行,主要集中在热带和亚热带地区。每年有多达 4 亿人感染登革热。约有 1 亿人因感染登革热而患病,4 万人死于严重的登革热。不幸的是,登革热疫苗的开发也受到各种复杂因素的影响,最前沿的候选疫苗表现并不令人满意。此外,针对 9 至 16 岁儿童的唯一许可疫苗(Dengvaxia)仅在少数几个国家有售。由于缺乏有效的抗病毒药物,治疗难度进一步加大。从实验室到临床应用,登革热植物疗法的探索涉及多个阶段,涵盖多个科学学科。个别研究人员筛选了多种植物提取物或化合物,以寻找其对登革热病毒的潜在抗病毒活性。体外研究有助于确定对病毒复制有抑制作用的候选药物。对 DENV 具有体外活性的一些最有希望的药用植物包括穿心莲、石菖蒲和东方蛤蚧。进一步的实验室研究,包括体外研究和动物模型(体内)研究,将阐明已确定的化合物发挥抗病毒作用的机制。木瓜(Carica papaya)、Cissampelos pareira 和 Ipomea batata 等药用植物表现出强大的血小板增强活性,而 Azadirachta indica 和 Curcuma longa 则在体外和体内研究中表现出良好的效果。根据积极的临床前研究结果,研究人员设计了临床试验。这涉及对试验阶段、患者招募标准、伦理考虑和终点的精心规划。在临床试验中显示出疗效和安全性的最重要的药用植物包括木瓜和 Cissampelos pareira。这篇综述表明,有几种前景看好的药用植物有可能成为治疗登革热感染的临床药物。然而,除了开发针对登革热感染的合成疗法和植物疗法外,还应制定强有力的病媒管理策略,强调必须把重点放在降低疾病发病率上。
{"title":"Exploring plant-based dengue therapeutics: from laboratory to clinic.","authors":"Bisma Rehman, Akhlaq Ahmed, Saeed Khan, Nida Saleem, Faiza Naseer, Sagheer Ahmad","doi":"10.1186/s40794-024-00232-1","DOIUrl":"10.1186/s40794-024-00232-1","url":null,"abstract":"<p><p>Dengue virus (DENV) is a mosquito-borne virus that causes dengue fever, a significant public health concern in many tropical and subtropical regions. Dengue is endemic in more than 100 countries, primarily in tropical and subtropical regions of the world. Each year, up to 400 million people get infected with dengue. Approximately 100 million people get sick from infection, and 40,000 die from severe dengue. Unfortunately, dengue vaccine development is also marred with various complicating factors, as the forefront candidate vaccine performed unsatisfactorily. Moreover, the only licensed vaccine (Dengvaxia) for children 9 through 16 years of age is available in just a few countries. The treatment difficulties are compounded by the absence of an effective antiviral agent. Exploring plant-based therapeutics for dengue from the laboratory to clinical application involves a multi-stage process, encompassing various scientific disciplines. Individual investigators have screened a wide range of plant extracts or compounds for potential antiviral activity against DENV. In vitro studies help identify candidates that exhibit inhibitory effects on viral replication. Some of the most promising medicinal plants showing in vitro activity against DENV include Andrographis paniculate, Acorus calamus, and Cladogynos orientalis. Further laboratory studies, both in vitro and in animal models (in vivo), elucidate the mechanisms of action by which the identified compounds exert antiviral effects. Medicinal plants such as Carica papaya, Cissampelos pareira, and Ipomea batata exhibited potent platelet-enhancing activities while Azadirachta indica and Curcuma longa showed promising effects in both in vitro and in vivo studies. Based on positive preclinical results, researchers design clinical trials. This involves careful planning of trial phases, patient recruitment criteria, ethical considerations, and endpoints. The most important medicinal plants showing efficacy and safety in clinical trials include Carica papaya and Cissampelos pareira. This review suggests that several promising medicinal plants exist that have the potential to be turned into clinical drugs to treat dengue infection. However, in addition to developing synthetic and plant-based therapies against dengue infection, vector management strategies should be made robust, emphasizing the need to focus on reducing disease incidence.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"23"},"PeriodicalIF":2.4,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of antibody-dependent enhancement in dengue vaccination. 抗体依赖性增强在登革热疫苗接种中的作用。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-11-01 DOI: 10.1186/s40794-024-00231-2
D G Aynekulu Mersha, I van der Sterren, L P M van Leeuwen, T Langerak, M S Hakim, B Martina, S F L van Lelyveld, E C M van Gorp

Dengue is the most rapidly spreading vector-borne disease worldwide, with over half the global population at risk for an infection. Antibody-dependent enhancement (ADE) is associated with increased disease severity and may also be attributable to the deterioration of disease in vaccinated people. Two dengue vaccines are approved momentarily, with more in development. The increasing use of vaccines against dengue, combined with the development of more, makes a thorough understanding of the processes behind ADE more important than ever. Above that, due to the lack of treatment options, this method of prevention is of great importance. This review aims to explore the impact of ADE in dengue vaccinations, with the goal of enhancing potential vaccination strategies in the fight against dengue.

登革热是全球传播最迅速的病媒传染病,全球有一半以上的人口面临感染风险。抗体依赖性增强(ADE)与疾病严重程度的增加有关,也可能是疫苗接种者病情恶化的原因。目前已有两种登革热疫苗获得批准,还有更多疫苗正在研发中。随着登革热疫苗的使用越来越多,以及更多疫苗的开发,彻底了解 ADE 背后的过程比以往任何时候都更加重要。此外,由于缺乏治疗方法,这种预防方法也非常重要。本综述旨在探讨 ADE 在登革热疫苗接种中的影响,目的是在对抗登革热的斗争中加强潜在的疫苗接种策略。
{"title":"The role of antibody-dependent enhancement in dengue vaccination.","authors":"D G Aynekulu Mersha, I van der Sterren, L P M van Leeuwen, T Langerak, M S Hakim, B Martina, S F L van Lelyveld, E C M van Gorp","doi":"10.1186/s40794-024-00231-2","DOIUrl":"10.1186/s40794-024-00231-2","url":null,"abstract":"<p><p>Dengue is the most rapidly spreading vector-borne disease worldwide, with over half the global population at risk for an infection. Antibody-dependent enhancement (ADE) is associated with increased disease severity and may also be attributable to the deterioration of disease in vaccinated people. Two dengue vaccines are approved momentarily, with more in development. The increasing use of vaccines against dengue, combined with the development of more, makes a thorough understanding of the processes behind ADE more important than ever. Above that, due to the lack of treatment options, this method of prevention is of great importance. This review aims to explore the impact of ADE in dengue vaccinations, with the goal of enhancing potential vaccination strategies in the fight against dengue.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"22"},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529159/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tropical Diseases, Travel Medicine and Vaccines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1